The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes

Abstract The World Health Organization (WHO) criteria for diagnosing and treating Tuberculosis (TB) includes clinical signs, therefore not requiring bacteriological laboratory confirmation. In resource-limited settings, including Kenya, this empirical TB treatment is routine practice however limited...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Osman Abdullahi, Ngari Moses, Deche Sanga, Willetts Annie
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5bbc281d25cb4535b83efeeb550b8459
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5bbc281d25cb4535b83efeeb550b8459
record_format dspace
spelling oai:doaj.org-article:5bbc281d25cb4535b83efeeb550b84592021-12-02T17:55:04ZThe effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes10.1038/s41598-021-94153-02045-2322https://doaj.org/article/5bbc281d25cb4535b83efeeb550b84592021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94153-0https://doaj.org/toc/2045-2322Abstract The World Health Organization (WHO) criteria for diagnosing and treating Tuberculosis (TB) includes clinical signs, therefore not requiring bacteriological laboratory confirmation. In resource-limited settings, including Kenya, this empirical TB treatment is routine practice however limited data exist on patient clinical outcomes when comparing the method of diagnosis. We evaluated TB treatment outcomes comparing clinically diagnosed and bacteriologically confirmed TB, 6 months after starting treatment of TB in a rural county in Kenya. Our analysis compared patients with a clinical versus a bacteriologically confirmed TB diagnosis. In this retrospective analysis, we included all adults (≥ 18 years) starting treatment of TB and followed up for 6 months, within the County TB surveillance database from 2012 to 2018. Patients included from both public and private facilities. The TB treatment outcomes assessed included treatment success, treatment failure, death, defaulted and transferred out. We used survival regression models to assess effect of type of diagnosis on TB treatment outcome defining time at risk from date of starting treatment to experiencing one of the treatment outcomes or completing 6-months of treatment. A total of 12,856 patients; median age 37 [IQR 28 − 50] years were included. 7639 (59%) were male while 11,339 (88%) were pulmonary TB cases. Overall, 11,633 (90%) were given first-line TB treatment and 3791 (29%) were HIV infected. 6472 (50%) of the patients were clinically diagnosed of whom 4521/6472 (70%) had a negative sputum/GeneXpert test. During the study 5565 person-years (PYs) observed, treatment success was 82% and 83% amongst clinically and bacteriologically diagnosed patients (P = 0.05). There were no significant differences in defaulting (P = 0.70) or transfer out (P = 0.19) between clinically and bacteriologically diagnosed patients. Mortality was significantly higher among clinically diagnosed patients: 639 (9.9%) deaths compared to 285 (4.5%) amongst the bacteriologically diagnosed patients; aHR 5.16 (95%CI 2.17 − 12.3) P < 0.001. Our study suggests survival during empirical TB treatment is significantly lower compared to patients with laboratory evidence, irrespective of HIV status and age. To improve TB treatment outcomes amongst clinically diagnosed patients, we recommend systematic screening for comorbidities, prompt diagnosis and management of other infections.Osman AbdullahiNgari MosesDeche SangaWilletts AnnieNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Osman Abdullahi
Ngari Moses
Deche Sanga
Willetts Annie
The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes
description Abstract The World Health Organization (WHO) criteria for diagnosing and treating Tuberculosis (TB) includes clinical signs, therefore not requiring bacteriological laboratory confirmation. In resource-limited settings, including Kenya, this empirical TB treatment is routine practice however limited data exist on patient clinical outcomes when comparing the method of diagnosis. We evaluated TB treatment outcomes comparing clinically diagnosed and bacteriologically confirmed TB, 6 months after starting treatment of TB in a rural county in Kenya. Our analysis compared patients with a clinical versus a bacteriologically confirmed TB diagnosis. In this retrospective analysis, we included all adults (≥ 18 years) starting treatment of TB and followed up for 6 months, within the County TB surveillance database from 2012 to 2018. Patients included from both public and private facilities. The TB treatment outcomes assessed included treatment success, treatment failure, death, defaulted and transferred out. We used survival regression models to assess effect of type of diagnosis on TB treatment outcome defining time at risk from date of starting treatment to experiencing one of the treatment outcomes or completing 6-months of treatment. A total of 12,856 patients; median age 37 [IQR 28 − 50] years were included. 7639 (59%) were male while 11,339 (88%) were pulmonary TB cases. Overall, 11,633 (90%) were given first-line TB treatment and 3791 (29%) were HIV infected. 6472 (50%) of the patients were clinically diagnosed of whom 4521/6472 (70%) had a negative sputum/GeneXpert test. During the study 5565 person-years (PYs) observed, treatment success was 82% and 83% amongst clinically and bacteriologically diagnosed patients (P = 0.05). There were no significant differences in defaulting (P = 0.70) or transfer out (P = 0.19) between clinically and bacteriologically diagnosed patients. Mortality was significantly higher among clinically diagnosed patients: 639 (9.9%) deaths compared to 285 (4.5%) amongst the bacteriologically diagnosed patients; aHR 5.16 (95%CI 2.17 − 12.3) P < 0.001. Our study suggests survival during empirical TB treatment is significantly lower compared to patients with laboratory evidence, irrespective of HIV status and age. To improve TB treatment outcomes amongst clinically diagnosed patients, we recommend systematic screening for comorbidities, prompt diagnosis and management of other infections.
format article
author Osman Abdullahi
Ngari Moses
Deche Sanga
Willetts Annie
author_facet Osman Abdullahi
Ngari Moses
Deche Sanga
Willetts Annie
author_sort Osman Abdullahi
title The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes
title_short The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes
title_full The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes
title_fullStr The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes
title_full_unstemmed The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes
title_sort effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5bbc281d25cb4535b83efeeb550b8459
work_keys_str_mv AT osmanabdullahi theeffectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
AT ngarimoses theeffectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
AT dechesanga theeffectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
AT willettsannie theeffectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
AT osmanabdullahi effectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
AT ngarimoses effectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
AT dechesanga effectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
AT willettsannie effectofempiricalandlaboratoryconfirmedtuberculosisontreatmentoutcomes
_version_ 1718379169704837120